Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adult neurogenesis in Parkinson’s disease
Franz Marxreiter, Martin Regensburger, Jürgen Winkler
Cellular and Molecular Life Sciences (2012) Vol. 70, Iss. 3, pp. 459-473
Closed Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease
Giselle M. Petzinger, Beth E. Fisher, Sarah McEwen, et al.
The Lancet Neurology (2013) Vol. 12, Iss. 7, pp. 716-726
Open Access | Times Cited: 672
Curcumin-Loaded Nanoparticles Potently Induce Adult Neurogenesis and Reverse Cognitive Deficits in Alzheimer’s Disease Model via Canonical Wnt/β-Catenin Pathway
Shashi Kant Tiwari, Swati Agarwal, Brashket Seth, et al.
ACS Nano (2013) Vol. 8, Iss. 1, pp. 76-103
Closed Access | Times Cited: 501
Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson’s Disease
Shankar J. Chinta, Georgia Woods, Marco Demaria, et al.
Cell Reports (2018) Vol. 22, Iss. 4, pp. 930-940
Open Access | Times Cited: 426
Effects of air pollution on the nervous system and its possible role in neurodevelopmental and neurodegenerative disorders
Lucio G. Costa, Toby B. Cole, Khoi Dao, et al.
Pharmacology & Therapeutics (2020) Vol. 210, pp. 107523-107523
Open Access | Times Cited: 351
Mitochondria as central regulators of neural stem cell fate and cognitive function
Mireille Khacho, Richard A. Harris, Ruth S. Slack
Nature reviews. Neuroscience (2018) Vol. 20, Iss. 1, pp. 34-48
Closed Access | Times Cited: 335
Adult Neurogenesis in Neurodegenerative Diseases: Figure 1.
Beate Winner, Jürgen Winkler
Cold Spring Harbor Perspectives in Biology (2015) Vol. 7, Iss. 4, pp. a021287-a021287
Open Access | Times Cited: 290
Neuroinflammation and Neurogenesis in Alzheimer’s Disease and Potential Therapeutic Approaches
Pi‐Shan Sung, Po‐Yu Lin, Chi‐Hung Liu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 701-701
Open Access | Times Cited: 153
Neurogenesis in aging and age-related neurodegenerative diseases
Luka Čulig, Xixia Chu, Vilhelm A. Bohr
Ageing Research Reviews (2022) Vol. 78, pp. 101636-101636
Open Access | Times Cited: 114
The Dialogue Between Neuroinflammation and Adult Neurogenesis: Mechanisms Involved and Alterations in Neurological Diseases
Mobina Amanollahi, Melika Jameie, Arash Heidari, et al.
Molecular Neurobiology (2022) Vol. 60, Iss. 2, pp. 923-959
Closed Access | Times Cited: 106
Glycogen Synthase Kinase 3 Inhibition Promotes Adult Hippocampal Neurogenesis in Vitro and in Vivo
José Á. Morales-García, Rosario Luna‐Medina, Sandra Alonso‐Gil, et al.
ACS Chemical Neuroscience (2012) Vol. 3, Iss. 11, pp. 963-971
Open Access | Times Cited: 147
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
Sandeep Vasant More, Dong‐Kug Choi
Molecular Neurodegeneration (2015) Vol. 10, Iss. 1
Open Access | Times Cited: 133
Neuronal replacement therapy: previous achievements and challenges ahead
Sofia Grade, Magdalena Götz
npj Regenerative Medicine (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 106
Impact of Environmental Risk Factors on Mitochondrial Dysfunction, Neuroinflammation, Protein Misfolding, and Oxidative Stress in the Etiopathogenesis of Parkinson’s Disease
Minhong Huang, Alejandra Bargues-Carot, Zainab Riaz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10808-10808
Open Access | Times Cited: 55
The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases
Dihe Cheng, Shuo Yang, Xue Zhao, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 665-684
Open Access | Times Cited: 39
Integration of miRNA’s theranostic potential with nanotechnology: Promises and challenges for Parkinson’s disease therapeutics
Kamatham Pushpa Tryphena, Gurpreet Singh, Naitik Jain, et al.
Mechanisms of Ageing and Development (2023) Vol. 211, pp. 111800-111800
Closed Access | Times Cited: 24
Adult Neurogenesis in the Subventricular Zone of Patients with Huntington's and Parkinson's Diseases and following Long‐Term Treatment with Deep Brain Stimulation
Marta Snapyan, Francis Desmeules, Jonathan Munro, et al.
Annals of Neurology (2025)
Open Access | Times Cited: 1
Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all?
Erin M. van Buel, Kostas Patas, Marvin Peters, et al.
Translational Psychiatry (2015) Vol. 5, Iss. 7, pp. e609-e609
Open Access | Times Cited: 85
Ethosuximide Induces Hippocampal Neurogenesis and Reverses Cognitive Deficits in an Amyloid-β Toxin-induced Alzheimer Rat Model via the Phosphatidylinositol 3-Kinase (PI3K)/Akt/Wnt/β-Catenin Pathway
Shashi Kant Tiwari, Brashket Seth, Swati Agarwal, et al.
Journal of Biological Chemistry (2015) Vol. 290, Iss. 47, pp. 28540-28558
Open Access | Times Cited: 84
Neurodegeneration in Parkinson's Disease: Interactions of Oxidative Stress, Tryptophan Catabolites and Depression with Mitochondria and Sirtuins
George Anderson, Michaël Maes
Molecular Neurobiology (2013) Vol. 49, Iss. 2, pp. 771-783
Closed Access | Times Cited: 83
Modulation of neurogenesis via neurotrophic factors in acupuncture treatments for neurological diseases
Hwa Kyoung Shin, Sae‐Won Lee, Byung Tae Choi
Biochemical Pharmacology (2017) Vol. 141, pp. 132-142
Closed Access | Times Cited: 76
S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson’s disease
Carmen R. Sunico, Tomohiro Nakamura, Edward Rockenstein, et al.
Molecular Neurodegeneration (2013) Vol. 8, Iss. 1
Open Access | Times Cited: 74
Abnormal hippocampal neurogenesis in Parkinson’s disease: relevance to a new therapeutic target for depression with Parkinson’s disease
Juhee Lim, Yeojin Bang, Hyun Jin Choi
Archives of Pharmacal Research (2018) Vol. 41, Iss. 10, pp. 943-954
Closed Access | Times Cited: 71
Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson’s disease: clues to early diagnosis and effective treatment
Yeojin Bang, Juhee Lim, Hyun Jin Choi
Archives of Pharmacal Research (2021) Vol. 44, Iss. 6, pp. 588-604
Open Access | Times Cited: 55
Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment
Michele Longoni Calió, Elisandra Henriques, Amanda Siena, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 54
α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy
Verena May, Benjamin Ettle, Anne-Maria Poehler, et al.
Neurobiology of Aging (2014) Vol. 35, Iss. 10, pp. 2357-2368
Open Access | Times Cited: 66
Page 1 - Next Page

Scroll to top